Acquisition includes wholly owned subsidiary businesses BioKey BV and BioClue BV. Platform is based on a proprietary biological discovery called HYFT™ patterns, signature sequences in DNA, RNA, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback